Glutamate/Aspartate Supplementation during Cardiopulmonary Bypass: Effect on Postoperative Neurocognitive Function
DOI:
https://doi.org/10.1532/HSF98.20071169Abstract
In this randomized trial, we investigated the effect of glutamate/aspartate-containing cardioplegia on neurocognitive function in 70 patients undergoing first-time elective coronary artery bypass graft surgery. Half of the patients received glutamate/aspartate, and the other 35 patients served as controls and received crystalloid cardioplegia. Neurocognitive function after surgery was assessed with the Mini-Mental State Examination performed before surgery and again on postoperative day 3. Although patients in both groups scored slightly lower postoperatively (17 versus 18 of a total of 30 points), no significant group differences were found. Our results indicate that glutamate/aspartate supplementation had no impact on neurocognitive function after coronary artery bypass graft surgery.References
Arrowsmith JE, Harrison MJG, Newman SP, et al. 1998. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 29:2357-5.nBach-y-Rita P. 2002. Volume transmission and brain plasticity. Evolution Cognition 8:115-7.nBhudia SK, Cosgrove DM, Naugle RI, et al. 2006. Magnesium as a neuroprotectant in cardiac surgery: A randomized clinical trial. J Thorac Cardiovasc Surg 131:853-8.nBronster DJ. 2006 Neurologic complications of cardiac surgery: current concepts and recent advances. Curr Cardiol Rep 8:9-7.nBrowne SM, Halligan PW, Wade DT, et al. 1999. Cognitive performance after cardiac operation: implications of regression toward the mean. J Thorac Cardiovasc Surg 117:481-4.nBruno V, Copani A, Knopfel T, et al. 1995. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology 34:1089-9.nBurker EJ, Blumenthal JA, Feldman M, et al. 1995. The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. Int J Psychiatry Med 25:263-13.nButterworth J, Hammon JW. 2002. Lidocaine for neuroprotection: more evidence of efficacy. Anesth Analg 95:1131-2.nGladstone DJ, Black SE, Hakim AM. 2002. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-3nHindman BJ, Todd MM. 1999. Improving neurologic outcome after cardiac surgery. Anesthesiology 90:1243-4.nKing N, McGivan JD, Griffiths EJ, et al. 2003. Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generation. J Mol Cell Cardiol 35:975-9.nLewis MS, Maruff PT, Silbert BS. 2005. Examination of the use of cognitive domains in postoperative cognitive dysfunction after coronary artery bypass graft. Ann Thorac Surg 80:910-6.nNagels W, Demeyere R, Hemelrijck JV, et al. 2004. Evaluation of the neuroprotective effects of S(+)-ketamine during open-heart surgery. Anesth Analg 98:1595-8.nNewman MF, Croughwell ND, Blumenthal JA, et al. 1996. Cardiopulmonary bypass and the central nervous system: potential for cerebral protection. J Clin Anesth 8(3 Suppl):53-7.nNewman S. 1995. Analysis and interpretation of neuropsychologic tests in cardiac surgery. Ann Thorac Surg 59:1351-4.nOzyurt E, Graham DI, Woodruff GN. 1988. Protective effect of the glutamate antagonist MK801 in focal cerebral ischaemia in the cat. J Cereb Blood Flow Metab 8:138-5.nPugsley W, Klinger L, Paschalis, et al. 1994. The impact of microemboli in cardiopulmonary bypass on neuropsychological functioning. Stroke 25:1393-6.nSmith HC, Hacke W, Hennerici M, et al. 1996. Lubeluzole in acute ischaemic stroke. Stroke 27:76-5.nSmith P, Treasure T, Newman S, et al. 1986. Cerebral consequences of cardiopulmonary bypass. Lancet 1:823-2.nSmith QR. 2000. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 130:1016-6.nStump D. 1995. Selection and clinical significance of neuropsychologic tests. Ann Thorac Surg 59:1340-4.nVizi ES. 2000. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in central nervous system. Pharmacol Rev 52:63-27.nWeissrock S, Levy F, Balabaud V, et al. 2005. Interest of the Mini Mental State Examination to detect cognitive defects after cardiac surgery. Ann Fr Anesth Reanim 24(10):1255-6.n
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
